Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
about
Emerging drugs of abuse: current perspectives on substituted cathinones.Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention.Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography-High-Resolution Mass Spectrometry and Post-run Library Matching.An overview of recent developments in the analytical detection of new psychoactive substances (NPSs).Applications and challenges in using LC-MS/MS assays for quantitative doping analysis.Ultrafast Screening of Synthetic Cannabinoids and Synthetic Cathinones in Urine by RapidFire-Tandem Mass Spectrometry.Forensic electrochemistry: the electroanalytical sensing of synthetic cathinone-derivatives and their accompanying adulterants in "legal high" products.Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots.Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis.Formation of odd-electron product ions in collision-induced fragmentation of electrospray-generated protonated cathinone derivatives: aryl α-primary amino ketones.Determination of designer drug cross-reactivity on five commercial immunoassay screening kits.Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.Quantitative measurement of synthetic cathinones in oral fluid.Regal electrochemistry: sensing of the synthetic cathinone class of new psychoactive substances (NPSs)Prevalence of new psychoactive substances in Victorian fatally-injured drivers
P2860
Q33706892-CDAA6312-6051-4B92-820F-7DEEF25AAB76Q35754464-3213FE6A-755D-4D87-BB37-841B461A3A16Q36088120-D75A64ED-CEB6-4CEC-AD22-072C8540D4F6Q38510888-26496490-A4DC-4D25-8698-7FE5217E1C7BQ38848680-7C6AB29F-01A2-4B9A-9C45-D99F767A24B2Q39761448-9EECA8D8-CCE7-42CD-A3B8-9CEB7131501BQ42238818-E5213EAC-CF42-451C-A0EF-499083C2255FQ44886525-EBF71AB3-5675-427F-A0CA-BDBDE2E824C3Q46456473-08F700C6-C8A9-416C-8618-9D54F62D7E3CQ46475968-AE15D784-3806-4932-A9E2-3B361FF69BB3Q53364460-75B3A8CC-89B7-4E01-8DFA-ED44327DF20EQ53479625-813E74CA-2EBF-406C-874D-B89A55125F29Q54765599-EFFFCC27-8FB0-4195-9700-F86FE4039D31Q57755145-98417766-DBB4-4100-B911-84C9C7CD9C26Q57986540-8CB1A61D-81DA-4BF1-BE76-84D4372C197D
P2860
Detection and quantification of new designer drugs in human blood: Part 2 - Designer cathinones.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Detection and quantification o ...... Part 2 - Designer cathinones.
@en
Detection and quantification o ...... Part 2 - Designer cathinones.
@nl
type
label
Detection and quantification o ...... Part 2 - Designer cathinones.
@en
Detection and quantification o ...... Part 2 - Designer cathinones.
@nl
prefLabel
Detection and quantification o ...... Part 2 - Designer cathinones.
@en
Detection and quantification o ...... Part 2 - Designer cathinones.
@nl
P2093
P356
P1476
Detection and quantification o ...... : Part 2 - Designer cathinones
@en
P2093
Dominic Ammann
Jenna M McLaren
Jochen Beyer
P304
P356
10.1093/JAT/BKS049
P577
2012-05-16T00:00:00Z